Pfizer (PFE)

Operating Expenses

$29.45B

TTM · Period ending: · USD

PFE logo

PFE Operating Expenses

Latest reported$29.45B
PFE TTM Operating Expenses (-$3.52B → $29.45B)
High-resolution chart · PNG

PFE operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pfizer Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
15,905,000,000
16,242,000,000
15,131,000,000
13,198,000,000
11,778,000,000
9,839,000,000
9,670,000,000
9,426,000,000
9,172,000,000
9,032,000,000
8,650,000,000
8,346,000,000
8,088,000,000
7,716,000,000
7,386,000,000
7,128,000,000
6,885,000,000
6,721,000,000
6,541,000,000
6,291,900,000
6,115,400,000
5,876,200,000
5,751,300,000
5,469,800,000
5,261,500,000
4,960,400,000
4,680,600,000
5,277,900,000
5,166,300,000
4,855,600,000
4,817,500,000
4,023,100,000
3,941,000,000
4,109,900,000
4,023,900,000
3,927,600,000
3,875,000,000
3,813,100,000
3,740,000,000
3,680,800,000
3,562,500,000
3,444,700,000
3,318,200,000
-2,361,900,000
-3,160,500,000
-3,970,700,000
-4,703,300,000
-4,373,500,000
-4,373,500,000
-4,373,500,000
-4,373,500,000
-3,979,000,000
-3,979,000,000
-3,979,000,000
-3,979,000,000
-3,516,300,000
-3,516,300,000
-3,516,300,000
-3,516,300,000
-3,144,500,000
-3,144,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.